SEARCH

SEARCH BY CITATION

References

  • 1
    MatthewsG, RobotinM, eds. B positive – all you wanted to know about hepatitis B: a guide for primary care providers. Darlinghurst , NSW : Australiasian Society for HIV Medicine (ASHM) & The Cancer Council NSW; 2008.
  • 2
    Dienstag J. Hepatitis B Virus Infection. N Engl J Med 2008;359:1486500.
  • 3
    Cowie B, Karapanagiotidis T, Enriquez A, Kelly H. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Aust N Z J Public Health 2010;34:728.
  • 4
    Kawsar M, Goh B. Hepatitis B virus infection among Chinese residents in the United Kingdom. Sex Transm Infect 2002;78:1668.
  • 5
    Tawk H, Vickery K, Bisset L, et al. The current pattern of hepatitis B virus infection in Australia. J Viral Hepat. 2006;13:20615.
  • 6
    Tong M, Hwang S. Hepatitis B virus infection in Asian Americans. Gastroenterol Clin North Am. 1994;23:52336.
  • 7
    Gidding H, Warlow M, MacIntyre C, et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine. 2007;25:863741.
  • 8
    Nelson K, Bui H, Samet J. Screening in special populations: a “case study” of recent Vietnamese immigrants. Am J Med. 1997;102:43540.
  • 9
    O'Sullivan B, Gidding H, Law M, Kaldor J, Gilbert G, Dore G. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health. 2004;28:2126.
  • 10
    NSW Department of Health. New South Wales Mothers and Babies 2006. NSW Public Health Bull. 2009;20:1156.
  • 11
    World Health Organization. Weekly Epidemiological Record. 2002:6:4148.
  • 12
    World Health Organization. Meeting of hepatitis B control through immunization. Tokyo, Japan: 26–28 June 2002. Manila : WHO Regional Office for Western Pacific; 2002.
  • 13
    Lesmana L, Leung N, Mahachai V, et al. Hepatitis B: overview of the burden of disease in the Asia-Pacific region. Liver Int. 2006;26:310.
  • 14
    Australian Bureau of Statistics. Census Data. In: Australian Bureau of Statistics, 2007.
  • 15
    Wallace J, McNally S, Richmond J. National Hepatitis B Needs Assessment 2007 [monograph on the Internet]. Melbourne : Australian Research Centre in Sex; 2007 [cited 2010 Jul 5] Available from: http://www.ashm.org.au/images/publications/guidelines/07hepbneedsassess_000.pdf.
  • 16
    Nguyen V, Razali K, Amin J, Law M, Dore G. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol. 2008;23:9229.
  • 17
    AIHW. Australian health inequalities: Birthplace. In. Canberra : Australian Institute of Health and Welfare. 2002.
  • 18
    Ushijima H, Dairaku M, Honma H, et al. Incidence of antibodies against human immunodeficiency virus, human T-cell lymphotropic virus type 1, hepatitis B virus, hemorrhagic fever with renal syndrome virus and chlamydia in Tonga and Western Samoa. Jpn J Med Sci Biol. 1990;43:1019.
  • 19
    Nguyen V, Law M, Dore G. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int. 2008;28:52531.
  • 20
    Sherif M, Abou-Aita B, Abou-Elew M, el-Kafrawi A. Hepatitis B Virus Infection in Upper and Lower Egypt. J Med Virol. 1985;15:12935.
  • 21
    Eftyhia V, Mary M, Duane B, Jo M, Alison C, John S. Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol. 1999;58:1115.
  • 22
    Kew M. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut. 1996;38:S316.
  • 23
    Jutavijittum P, Yousukh A, Samountry B, et al. Seroprevalence of hepatitis B and C virus infections among Lao blood donors. Southeast Asian J Trop Med Public Health. 2007;38:6749.
  • 24
    Nakai K, Win K, Oo S, Arakawa Y, Abe K. Molecular characteristic-based epidemiology of hepatitis B, C, and E viruses and GB virus C/hepatitis G virus in Myanmar. J Clin Microbiol. 2001;39:15369.
  • 25
    Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ. 1999;77:78997.
  • 26
    Wilson N, Ruff T, Rana B, Leydon J, Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine. 2000;18:305966.
  • 27
    Nardone A, Anastassopoulou C, Theeten H, et al. A comparison of hepatitis B seroepidemiology in ten European countries. Epidemiol Infect. 2009;137:9619.
  • 28
    Elsheikh RM, Daak AA, Elsheikh MA, et al. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. J Virol. 2007;4:104.
  • 29
    Ali H. Hepatitis B infection among Iraqi children: the impact of sanctions. Eastern Mediterranean Health Journal. 2004;10:611.
  • 30
    Batayneh N, Bdour S, Batayneh N, Bdour S. Risk of perinatal transmission of hepatitis B virus in Jordan. Infectious Diseases in Obstetrics & Gynecology. 2002;10:12732.
  • 31
    Custer B, Sullivan S, Hazlet T, Iloeje U, Veenstra D, Kowdley K. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38:S15868.
  • 32
    Chironna M, Germinario C, Lopalco P, Carrozzini F, Quarto M. Prevalence of hepatitis virus infections in Kosovar refugees. The International Journal of Infectious Diseases. 2001;5:20913.
  • 33
    Salkic N, Zildzic M, Muminhodzic K, et al. Intrafamilial transmission of hepatitis B in Tuzla region of Bosnia and Herzegovina. Eur J Gastroenterol Hepatol. 2007;19:1138.
  • 34
    Song E, Yun Y, Park M, Seo D. Prevalence of occult hepatitis B virus infection in a general adult population in Korea. Intervirology. 2009;52:5762.
  • 35
    Manandhar K, Shrestha B. Prevalence of hepatitis B virus infection amongst healthy Nepalese males. Trop Gastroenterol. 1998;19:1457.
  • 36
    Lansang M. Epidemiology and control of hepatitis B infection: a perspective from the Philippines. Gut. 1996;38:S437.
  • 37
    James L, Fong C, Foong B, et al. Hepatitis B Seroprevalence Study 1999. Singapore Med J. 2001;42:4204.
  • 38
    Vildosola H, Farfan G, Colan E, et al. [Prevalence of hepatitis B surface antigen in general population of coast, mountain and forest regions of Peru. A preliminary report]. Revista de Gastroenterologia del Peru 1990;10:96101.
  • 39
    Othman BM, Monem FS, Othman BM, Monem FS. Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria. Saudi Medical Journal. 2002;23:3935.
  • 40
    Merat S, Rezvan H, Nouraie M, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Archives of Iranian Medicine. 2009;12:22531.
  • 41
    Batham A, Narula D, Toteja T, Sreenivas V, Puliyel J. Systematic review and meta-analysis of prevalence of hepatitis B in India. Indian Pediatr. 2007;44:66374.
  • 42
    Nabulsi M, El Saleeby C, Araj G, Lebanese Hepatitis B Collaborative Study Group. The current status of hepatitis B in Lebanon. The Lebanese Medical Journal. 2003;51:6470.
  • 43
    Gogos C, Fouka K, Nikiforidis G, et al. Prevalence of hepatitis B and C virus infection in the general population and selected groups in South-Western Greece. Eur J Epidemiol. 2003;18:5517.
  • 44
    Ali S, Donahue R, Qureshi H, Vermund S. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. The International Journal of Infectious Diseases. 2009;13:919.